Professor @tompowles1 joins our Clinical Advisory Board! His expertise will be invaluable as we advance our pipeline. Welcome, Thomas! #Oncology

Today, we reported second quarter 2026 financial results and recent business progress. Read our press release here: bit.ly/4frIAtc

Celebrating another successful year of our UK university student placement program! We're proud to support the next generation of scientists, reflecting our commitment to investing in our people and the spirit of #TeamBicycle. Wishing them the best and we can't wait to see their future impact!

Our team attended the 'Radionuclide Theranostics for the Management of Cancer' GRC last week. Matthew Bell & Siva Genapathy presented promising first-in-human data with Bicycle® Radioconjugates (BRC®) for rapid, high-contrast imaging of MT1-MMP & EphA2 tumors across multiple cancer indications. #Radiopharmaceuticals #PrecisionOncology #CancerResearch

15 team members conquered 21 obstacles at #ToughMudder, Belvoir Castle, with all 15 crossing the finish line together. An inspiring display of teamwork and camaraderie! #TeamBicycle

Honored to host Sec. of State @leicesterliz, showcasing our pioneering oncology & radiopharmaceutical innovations. We highlighted our landmark partnership that seeks to turn legacy nuclear material into targeted alpha therapies (BRCs®), contributing to UK leadership in precision medicine & nurturing STEM talent. #UKInnovation #Oncology #Radiopharmaceuticals #STEM

We held another successful UK Science Fair, an annual event hosted by our Research & Innovation Team to showcase the research being conducted at Bicycle Therapeutics. Special shoutout to the organizing committee, led by Monika Maciuszek and Peter Brown.

Check out our new publication: "The Journey of Targeted Drug Conjugates in Solid Tumors: Moving Beyond Antibody Drug Conjugates", showcasing the transformative potential of novel targeted therapies beyond ADCs. Read the publication: bit.ly/4aDaCyX

Excited to share a new publication in European Journal of Nuclear Medicine and Molecular Imaging highlighting clinical experiences with Bicycle Imaging Agents and their potential as a diagnostic tool for EphA2-positive malignancies. Read the publication: bit.ly/43e7kxZ

Last night, Jennifer Perry joined esteemed clinical and industry experts at the Women Leaders in Oncology and Allies Event, hosted in collaboration with @ConquerCancerFd. We're proud of JP and grateful for her work helping elevate women across our field.

This morning at #ASCO2026, Dr. Yohann Loriot presented initial Duravelo-2 data evaluating zelenectide pevedotin in combination with pembrolizumab. In case you missed it, the presentation is available here: bit.ly/43e7kxZ

Today, we announced initial Duravelo-2 data evaluating zelenectide pevedotin in previously untreated patients with metastatic urothelial cancer. We are excited to present these data at #ASCO2026. Press release is available here: bit.ly/3PvMpmL

Today, we reported first quarter 2026 financial results and recent business progress. Read our press release here: bit.ly/4tf0frO

We are excited to present at #ASCO2026, with multiple presentations highlighting the clinical activity seen from Bicycle® molecules. Find more details on our presentations here: bit.ly/4mGsQEB

At #AACR2026, we presented nuzefatide pevedotin data demonstrating a safety profile differentiated from antibody-based approaches and DKFZ presented human imaging data of a Bicycle® Imaging Agent (BIA) targeting EphA2. Posters are available here: bit.ly/4expNwm

We hopped into the Easter spirit with an amazing egg hunt around the office! 🐰 A huge thank you to our FAB team for organizing a day filled with fun, laughter, and some very friendly competition. It was fantastic to see everyone take a break, search for hidden treasures, and even hang out with a couple of giant rabbits who joined the festivities! It’s moments like these that make our team so special. #TeamBicycle #FunatBicycle #EasterEggHunt #BehindBicycle

We are reflecting on an inspiring weekend at the Cambridge Festival's Family Weekend. Thank you to the community members who visited our stand. Sharing our work and inspiring future scientists was a privilege. Our gratitude extends to the festival organizers and our dedicated volunteer team. #CambridgeFestival #STEM #CommunityEngagement #BicycleTX #Science #InspiringTheFuture #ThankYou

Thrilled to announce internal leadership changes to power our next phase of innovation in #oncology! Congratulations to Jennifer Perry, our new Chief Operating Officer, and Alistair Milnes, our new Chief Corporate Development Officer. These internal transitions showcase our team's incredible talent. Learn more: bit.ly/4uPChVT

Get ready for fun & discovery! 🔬 Bicycle Therapeutics is thrilled to be at the #CambridgeFestival #FamilyWeekend, March 28-29, 2026! Join us for hands-on science activities designed to inspire the next generation. We can't wait to connect with our community! #STEM #ScienceForKids #CommunityEngagement #BicycleTX #InspireTheNextGen